264 related articles for article (PubMed ID: 22169947)
41. Influence of early stress on memory reconsolidation: Implications for post-traumatic stress disorder treatment.
Villain H; Benkahoul A; Birmes P; Ferry B; Roullet P
PLoS One; 2018; 13(1):e0191563. PubMed ID: 29352277
[TBL] [Abstract][Full Text] [Related]
42. Acute but Not Permanent Effects of Propranolol on Fear Memory Expression in Humans.
Chalkia A; Weermeijer J; Van Oudenhove L; Beckers T
Front Hum Neurosci; 2019; 13():51. PubMed ID: 30846933
[TBL] [Abstract][Full Text] [Related]
43. Immediate post-defeat infusions of the noradrenergic receptor antagonist propranolol impair the consolidation of conditioned defeat in male Syrian hamsters.
Gray CL; Krebs-Kraft DL; Solomon MB; Norvelle A; Parent MB; Huhman KL
Physiol Behav; 2015 Dec; 152(Pt A):56-61. PubMed ID: 26367452
[TBL] [Abstract][Full Text] [Related]
44. Consolidation and reconsolidation are impaired by oral propranolol administered before but not after memory (re)activation in humans.
Thomas É; Saumier D; Pitman RK; Tremblay J; Brunet A
Neurobiol Learn Mem; 2017 Jul; 142(Pt A):118-125. PubMed ID: 28003127
[TBL] [Abstract][Full Text] [Related]
45. Xenon impairs reconsolidation of fear memories in a rat model of post-traumatic stress disorder (PTSD).
Meloni EG; Gillis TE; Manoukian J; Kaufman MJ
PLoS One; 2014; 9(8):e106189. PubMed ID: 25162644
[TBL] [Abstract][Full Text] [Related]
46. Opening the reconsolidation window using the mind's eye: Extinction training during reconsolidation disrupts fear memory expression following mental imagery reactivation.
Grégoire L; Greening SG
Cognition; 2019 Feb; 183():277-281. PubMed ID: 30529682
[TBL] [Abstract][Full Text] [Related]
47. Noradrenergic stimulation increases fear memory expression.
Kausche FM; Zerbes G; Kampermann L; Müller JC; Wiedemann K; Büchel C; Schwabe L
Eur Neuropsychopharmacol; 2021 Feb; 43():71-81. PubMed ID: 33358539
[TBL] [Abstract][Full Text] [Related]
48. Enhanced noradrenergic activity by yohimbine and differential fear conditioning in patients with major depression with and without adverse childhood experiences.
Kuehl LK; Deuter CE; Hellmann-Regen J; Kaczmarczyk M; Otte C; Wingenfeld K
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109751. PubMed ID: 31446157
[TBL] [Abstract][Full Text] [Related]
49. No evidence for blocking the return of fear by disrupting reconsolidation prior to extinction learning.
Klucken T; Kruse O; Schweckendiek J; Kuepper Y; Mueller EM; Hennig J; Stark R
Cortex; 2016 Jun; 79():112-22. PubMed ID: 27111105
[TBL] [Abstract][Full Text] [Related]
50. Delayed extinction fails to reduce skin conductance reactivity to fear-conditioned stimuli.
Fricchione J; Greenberg MS; Spring J; Wood N; Mueller-Pfeiffer C; Milad MR; Pitman RK; Orr SP
Psychophysiology; 2016 Sep; 53(9):1343-51. PubMed ID: 27314560
[TBL] [Abstract][Full Text] [Related]
51. Anticholinergic drug atropine diminishes newly formed fear memory in male rats.
Rafiq S; Ahmad S; Ahmed F; Batool Z; Ahmed SB; Saleem S; Naqvi F; Liaquat L; Afzal A; Haider S
Pak J Pharm Sci; 2018 May; 31(3(Supplementary)):1075-1079. PubMed ID: 29731446
[TBL] [Abstract][Full Text] [Related]
52. β-Adrenoceptor Blockade in the Basolateral Amygdala, But Not the Medial Prefrontal Cortex, Rescues the Immediate Extinction Deficit.
Giustino TF; Seemann JR; Acca GM; Goode TD; Fitzgerald PJ; Maren S
Neuropsychopharmacology; 2017 Dec; 42(13):2537-2544. PubMed ID: 28462941
[TBL] [Abstract][Full Text] [Related]
53. Beyond extinction: erasing human fear responses and preventing the return of fear.
Kindt M; Soeter M; Vervliet B
Nat Neurosci; 2009 Mar; 12(3):256-8. PubMed ID: 19219038
[TBL] [Abstract][Full Text] [Related]
54. Reconsolidation in a human fear conditioning study: a test of extinction as updating mechanism.
Kindt M; Soeter M
Biol Psychol; 2013 Jan; 92(1):43-50. PubMed ID: 21986472
[TBL] [Abstract][Full Text] [Related]
55. Stress disrupts the reconsolidation of fear memories in men.
Meir Drexler S; Wolf OT
Psychoneuroendocrinology; 2017 Mar; 77():95-104. PubMed ID: 28024275
[TBL] [Abstract][Full Text] [Related]
56. Effects of β-adrenergic receptor blockade on drug-related memory reconsolidation in abstinent heroin addicts.
Zhao LY; Sun LL; Shi J; Li P; Zhang Y; Lu L
Drug Alcohol Depend; 2011 Nov; 118(2-3):224-9. PubMed ID: 21531091
[TBL] [Abstract][Full Text] [Related]
57. L-DOPA improves extinction memory retrieval after successful fear extinction.
Gerlicher AMV; Tüscher O; Kalisch R
Psychopharmacology (Berl); 2019 Dec; 236(12):3401-3412. PubMed ID: 31243481
[TBL] [Abstract][Full Text] [Related]
58. Neural signature of reconsolidation impairments by propranolol in humans.
Schwabe L; Nader K; Wolf OT; Beaudry T; Pruessner JC
Biol Psychiatry; 2012 Feb; 71(4):380-6. PubMed ID: 22129757
[TBL] [Abstract][Full Text] [Related]
59. Effects of noradrenergic stimulation on memory in patients with major depressive disorder.
Wingenfeld K; Kuffel A; Uhlmann C; Terfehr K; Schreiner J; Kuehl LK; Otte C; Löwe B; Spitzer C
Stress; 2013 Mar; 16(2):191-201. PubMed ID: 22746337
[TBL] [Abstract][Full Text] [Related]
60. Disruptive effect of midazolam on fear memory reconsolidation: decisive influence of reactivation time span and memory age.
Bustos SG; Maldonado H; Molina VA
Neuropsychopharmacology; 2009 Jan; 34(2):446-57. PubMed ID: 18509330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
